Major pharmaceutical companies are increasingly adopting artificial intelligence to speed up drug discovery and reduce research costs. Industry leaders report that AI-driven platforms are helping identify potential drug candidates faster, optimize clinical trial design, and…

Read more

The European Union has reached a landmark agreement to reform drug regulations, aiming to speed up patient access to medicines across the bloc. The new framework revises data and market exclusivity rules, supports antibiotic innovation, and strengthens supply…

Read more

As a practising doctor in India, I’m encouraged by the latest development: Dr Reddy’s Laboratories has signed an exclusive licensing agreement with Australia-based Immutep to market a promising new cancer drug — a move that could expand therapeutic options for patients across the…

Read more

As a doctor, I’m genuinely excited about a recent milestone in Indian medicine — the launch of Nafithromycin, the first antibiotic discovered, developed and clinically validated entirely in India.

This antibiotic — marketed as Miqnaf — promises a short, once-daily, three-day treatment for…

Read more

This week, the U.S. Food and Drug Administration (FDA) approved Plozasiran (brand name: Redemplo) — a new siRNA therapy for Familial Chylomicronemia Syndrome (FCS), a rare genetic disorder that causes dangerously high triglyceride levels.

✅ What This Means from a Doctor’s Perspective

• For…

Read more

I’m deeply concerned—but also cautiously hopeful—about the recent anti‑dumping probe India has launched into imports of Ethambutol Hydrochloride, a key API used in TB drugs.

From a medical standpoint:

• Access to TB medicines is non-negotiable—we rely on affordable, consistent supply to treat…

Read more

As a physician who increasingly relies on digital health tools, I find India’s latest move hugely significant: the CDSCO has published a draft guidance document for medical-device software (SaMD and SiMD), including AI/ML-based applications.

What this means for us at…

Read more

As a doctor, here’s why this matters for all of us in healthcare:

• Stronger…

Read more

As a physician, I pay attention not only to new medicines but also to how the pharma industry is evolving — because stronger companies often mean better supply, better innovation and improved access for my patients. Glenmark Pharmaceuticals…

Read more

As a practicing physician, I believe meaningful change in healthcare doesn’t just come from new drugs — it comes from smarter systems too. Recently, the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam introduced the “i-Passport”, a streamlined gateway for med-tech and health-tech…

Read more

Novo Nordisk has cut the Indian price of its weight-loss drug Wegovy (semaglutide) by up to 37%.
Why this matters:

• Affordability is a major barrier in real-world practice; price reductions can increase adoption and allow more patients access.

• However, it also raises expectations: if we use the drug…

Read more

As a physician, patient safety is always front and centre—and recent regulatory action in India demands our attention. The Central Drugs Standard Control Organisation (CDSCO) has mandated that all pharmaceutical manufacturers must meet international standards by January 1, 2026—following a tragic…

Read more

Two recent announcements stand out for us in clinical practice:

• Finerenone (brand name Kerendia) has just received expanded approval in India for treating adult patients with heart‐failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF). This opens up treatment for a…

Read more

As a clinician, I welcome any move that speeds access to safe, affordable equipment—but only if safety keeps pace. India will now allow self-certification for over a thousand low- to moderate-risk medical devices (think stethoscopes, wheelchairs, swabs, scissors). The aim…

Read more

As a physician, the recent developments in India’s pharmaceutical industry have been deeply unsettling. Authorities have issued a hard-hitting advisory after discovering that multiple manufacturing facilities failed to test every batch of raw materials or…

Read more

In my practice, the moment a new drug emerges from trials into the real world, everything changes. While randomized controlled trials give us foundational safety and efficacy, it’s real-world evidence (RWE) that reveals how treatments perform in everyday settings—across comorbidities,…

Read more

As a doctor, I’ve seen a major transformation in how the pharmaceutical industry connects with healthcare professionals — and it’s all thanks to virtual meetings. What used to be long in-person sessions or conferences has now evolved into focused, efficient digital…

Read more

As a doctor, I’ve always believed that the foundation of good healthcare lies in communication — between clinicians, patients, researchers, and the pharmaceutical industry. Yet, for decades, that communication has often been fragmented and slow. Today, Artificial…

Read more

As a doctor, I’ve witnessed how digital collaboration platforms are transforming the healthcare industry. Platforms like HealthSocial allow doctors, researchers, and pharma professionals to exchange ideas instantly — breaking silos that once slowed progress.

Whether it’s…

Read more

As a clinician deeply invested in both patient safety and pharmaceutical integrity, recent events surrounding contaminated cough syrups in India have shaken me to the core. This isn’t just “another pharma scandal” — it’s a stark warning that regulatory gaps, quality lapses,…

Read more

As a doctor, I’ve always viewed India’s pharmaceutical sector with a sense of pride — it’s often called “the pharmacy of the world.” Over the past decade, Indian pharma exports have grown remarkably, supplying affordable and quality medicines to more than 200…

Read more

As a physician who often deals with shortages or long lead times for imaging and critical care equipment, this update is very encouraging. Premier Medical Systems (Medisys), one of India’s earliest medical-equipment makers, has secured a letter of…

Read more

The Central Drugs Standard Control Organisation (CDSCO) has approved eight new medicines in 2025, marking a significant step forward in India’s healthcare sector. These approvals encompass a range of…

Read more

In Hyderabad, the LV Prasad Eye Institute (LVPEI) ran a study in children with retinoblastoma (a rare but serious eye cancer). Traditionally, recurrences or resistant tumors are treated with intravitreal injections of melphalan, but at higher doses that can damage…

Read more

Recently, one of my heart patients showed me how his smartwatch had picked up irregular beats before he even felt symptoms. That moment reminded me how far we’ve come — and how much further we can go.

Wearables today track heart rate, sleep, oxygen levels, and even stress. But what…

Read more

When I look back at how I practiced medicine even a decade ago, the changes in our industry feel nothing short of remarkable.

Take diagnostics — once, waiting for CT or MRI reports could delay treatment decisions. Today, with faster imaging and AI-assisted reporting, I often get actionable insights within…

Read more

As a doctor, I sometimes forget how much of the medicines I prescribe today are shaped by AI working behind the scenes in pharma. It’s no longer just futuristic — I see it in daily practice.

Consider antibiotics. With resistance rising, I often worry if I’m choosing the right one. Now, pharma…

Read more

Several changes are underway that affect us in clinical practice:

• The DCGI / CDSCO is pushing faster drug approvals, especially for rare disease therapies and advanced treatments (like gene therapies).

• Drug licensing systems are being digitized: state + central…

Read more

As doctors, we often focus on lab…

Read more

A new global survey published in The Lancet highlights that over 60% of doctors report high levels of burnout, citing long hours, administrative overload, and staffing shortages. Personally, I see colleagues struggling with exhaustion and sometimes questioning whether to continue in clinical practice. Burnout not only affects…

Read more

The Indian healthcare sector is rapidly embracing artificial intelligence, with adoption rates now surpassing FMCG and manufacturing.

In hospitals, AI is being used for diagnostics (image analysis, CT/X-ray interpretation), predictive analytics (anticipating disease outbreaks, patient deterioration), and…

Read more

Welcome to Pharma News!
This group is dedicated to sharing the latest updates, insights, and developments from the pharmaceutical industry. 🧪💊

I’ll be regularly posting news, trends, and important information to help us all stay updated and informed.

Looking forward to engaging discussions and knowledge sharing with all of…